Our Pricing

Wegovy vs Saxenda: Which Weight Loss Injection Is Right for You?

When comparing wegovy vs saxenda, understanding the key differences between these two GLP-1 receptor agonists is essential for making an informed decision about your weight loss journey. Both medications have been proven effective in clinical trials, but they differ in active ingredient, dosing frequency, and weight loss outcomes. At Cured Pharmacy, our UK-registered clinical team helps patients navigate this choice through a free online consultation, ensuring you receive the most suitable treatment subject to prescriber approval.

Wegovy vs Saxenda: Active Ingredients and Mechanism

The fundamental difference in the wegovy vs saxenda comparison lies in their active ingredients. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics the naturally occurring hormone glucagon-like peptide-1, which regulates appetite and food intake [1]. Saxenda, by contrast, contains liraglutide, an earlier-generation GLP-1 analogue with a shorter half-life [2].

Both medications work by slowing gastric emptying, reducing appetite, and increasing feelings of fullness after meals. However, semaglutide in Wegovy has a longer duration of action, allowing for once-weekly dosing compared to Saxenda's daily injections [1]. This pharmacological difference significantly impacts treatment adherence and patient convenience, with clinical data suggesting once-weekly regimens improve long-term compliance in weight management programmes [3].

Clinical Trial Data: Wegovy vs Saxenda Weight Loss Results

When evaluating wegovy vs saxenda effectiveness, the clinical trial evidence provides clear guidance. The STEP 1 trial demonstrated that patients taking Wegovy achieved an average weight loss of 14.9% of their body weight over 68 weeks, compared to 2.4% with placebo [1]. In contrast, the SCALE Obesity and Prediabetes trial showed Saxenda users lost an average of 8.0% of their body weight over 56 weeks, versus 2.6% with placebo [2].

These results suggest Wegovy may offer superior weight loss outcomes for many patients, though individual responses vary considerably. Both medications require commitment to lifestyle modifications including dietary changes and increased physical activity to optimise results [3]. At Cured Pharmacy, our prescribers assess your medical history, weight loss goals, and personal circumstances to recommend the most appropriate option during your clinical consultation.

Real-World Effectiveness Beyond Clinical Trials

Real-world data supports the clinical trial findings in the wegovy vs saxenda debate. Post-marketing surveillance and observational studies indicate that patients using semaglutide-based treatments maintain weight loss more effectively at 12-month follow-up compared to liraglutide users [4]. However, both medications demonstrate significantly better outcomes than lifestyle intervention alone, and the best choice depends on individual tolerance, injection frequency preference, and prescriber recommendation.

Wegovy vs Saxenda: Dosing and Administration Differences

The dosing schedules represent a major practical difference in the wegovy vs saxenda comparison. Wegovy is administered once weekly via subcutaneous injection, starting at 0.25mg and gradually escalating to a maintenance dose of 2.4mg over 16-20 weeks [1]. This dose escalation minimises gastrointestinal side effects while allowing the body to adjust to the medication.

Saxenda requires daily subcutaneous injections, beginning at 0.6mg and increasing weekly to a maintenance dose of 3.0mg [2]. The daily injection requirement may suit patients who prefer more frequent, lower-dose administration or those who find daily routines easier to maintain. Both medications are self-administered using pre-filled injection pens, and our pharmacy team at Cured Pharmacy provides comprehensive guidance on proper injection technique and site rotation to ensure optimal absorption and comfort.

Side Effects Profile: Wegovy vs Saxenda Safety Comparison

When comparing wegovy vs saxenda side effects, both medications share a similar adverse event profile due to their GLP-1 mechanism of action. The most commonly reported side effects include nausea, diarrhoea, vomiting, constipation, and abdominal pain, typically occurring during dose escalation phases [1][2]. These gastrointestinal symptoms are generally mild to moderate and diminish over time as the body adapts to treatment.

Clinical trials indicate that nausea occurs in approximately 44% of Wegovy users and 39% of Saxenda users, though severe cases leading to discontinuation remain uncommon [1][2]. More serious but rare risks include pancreatitis, gallbladder disease, and potential thyroid C-cell tumours observed in rodent studies, though human relevance remains uncertain [5]. Both medications carry contraindications for patients with personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2.

Managing Side Effects During Treatment

Regardless of your choice in the wegovy vs saxenda decision, managing side effects requires proactive strategies. Eating smaller, more frequent meals, avoiding high-fat foods, staying well-hydrated, and adhering to the prescribed dose escalation schedule can significantly reduce gastrointestinal discomfort [3]. Our clinical team at Cured Pharmacy monitors patient progress and can adjust dosing schedules if side effects become problematic, always prioritising patient safety and treatment tolerability.

Cost Analysis: Wegovy vs Saxenda UK Pricing with Discount Codes

Price is often a deciding factor in the wegovy vs saxenda choice for UK patients. At Cured Pharmacy, Wegovy is available from £69.00 and Saxenda from £69.00, both representing competitive UK pricing with transparent upfront costs shown before your clinical consultation. New patients can Save £20 on their first order using discount code Weightlossnew, making these evidence-based treatments more accessible.

When calculating long-term costs, consider that Wegovy's once-weekly dosing may offer better value over extended treatment periods compared to Saxenda's daily injections, depending on the specific dose and pack size prescribed. Both medications require ongoing treatment to maintain weight loss, and discontinuation often results in weight regain [4]. Our superintendent pharmacist, Tarun Kumar (GPhC 2233073), ensures all pricing remains transparent and that patients understand the financial commitment involved in sustained weight management therapy.

Making Your Choice: Wegovy vs Saxenda Suitability Assessment

Deciding between wegovy vs saxenda requires individualised clinical assessment. Wegovy may be more suitable for patients seeking maximum weight loss potential, those who prefer once-weekly injections, or individuals who have not achieved adequate results with other GLP-1 treatments [1]. Saxenda might be preferred by patients who favour daily dosing routines, require a lower starting price point, or have specific medical considerations identified during prescriber consultation.

Both medications are licensed by the MHRA for weight management in adults with a BMI of 30 kg/m² or greater, or 27 kg/m² or greater in the presence of weight-related comorbidities such as type 2 diabetes, hypertension, or dyslipidaemia [5]. At Cured Pharmacy, our free online consultation takes under 3 minutes and allows our UK-registered prescribers to review your medical history, current medications, and weight loss goals to recommend the most appropriate treatment. All prescription medicines require clinical assessment and approval by a qualified UK prescriber before dispensing.

Next Steps with Cured Pharmacy

Starting your wegovy vs saxenda journey with Cured Pharmacy ensures you receive genuine UK-licensed medicines, expert clinical guidance, and discreet packaging delivered to your door. Our GPhC-registered pharmacy (9012511) guarantees the lowest prices in the UK with no hidden fees. Complete your medical assessment today, apply discount code Weightlossnew for £20 off, and take the first step toward sustainable weight loss with professional support from our experienced clinical team.

Scientific References

1. Wilding, J. P., Batterham, R. L., Calanna, S., Davies, M., Van Gaal, L. F., Lingvay, I., ... & Kushner, R. F. (2021). Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine, 384(11), 989-1002. [accessed 15 August 2026]
2. Pi-Sunyer, X., Astrup, A., Fujioka, K., Greenway, F., Halpern, A., Krempf, M., ... & Wilding, J. P. (2015). A randomized, controlled trial of 3.0 mg of liraglutide in weight management. New England Journal of Medicine, 373(1), 11-22. [accessed 15 August 2026]
3. Garvey, W. T., Batterham, R. L., Bhatta, M., Buscemi, S., Christensen, L. N., Frias, J. P., ... & Wharton, S. (2022). Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial. Nature Medicine, 28(10), 2083-2091. [accessed 15 August 2026]
4. Wilding, J. P., Batterham, R. L., Davies, M., Van Gaal, L. F., Kandler, K., Konakli, K., ... & Kushner, R. F. (2022). Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension. Diabetes, Obesity and Metabolism, 24(8), 1553-1564. [accessed 15 August 2026]
5. Medicines and Healthcare products Regulatory Agency. (2023). Wegovy 0.25 mg, 0.5 mg, 1 mg, 1.7 mg, 2.4 mg solution for injection in pre-filled pen: Summary of Product Characteristics. MHRA. [accessed 15 August 2026]
6. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 15 August 2026.
7. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 15 August 2026.
8. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 15 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.